Results 191 to 200 of about 79,996 (276)

Safety evaluation of the food enzyme thermolysin from the non‐genetically modified Anoxybacillus caldiproteolyticus strain DP‐Fzj32

EFSA Journal, Volume 24, Issue 6, June 2026.
Abstract The food enzyme thermolysin (EC 3.4.24.27) is produced with the non‐genetically modified Anoxybacillus caldiproteolyticus strain DP‐Fzj32 by Danisco US Inc. The food enzyme was considered free from viable cells of the production organism. It is intended to be used in three food manufacturing processes.
EFSA Panel on Food Enzymes (FEZ), Holger Zorn, José Manuel Barat Baviera, Claudia Bolognesi, Francesco Catania, Gabriele Gadermaier, Ralf Greiner, Baltasar Mayo, Alicja Mortensen, Yrjö Henrik Roos, Marize L. M. Solano, Henk Van Loveren, Laurence Vernis, Cristina Andreoli, Andrea Terron, Natália Kovalkovičová, Magdalena Andryszkiewicz, Daniele Cavanna, Ana Gomes, Yi Liu   +19 more
wiley   +1 more source

A Case of Severe Prekallikrein Deficiency Manifesting as Isolated Activated Partial Thromboplastin Time (aPTT) Prolongation. [PDF]

Cureus
Viswanathan D, Sivanandam A, Yeung V.
europepmc   +1 more source

Mechanism and modification of rejection of heterografts between divergent species. [PDF]

, 1970
Amemiya, H, Boehmig, HJ, Coburg, AJ, Dixon, FJ, Giles, GR, Hathaway, WE, Lilly, J, Starzl, TE, Takagi, H, Wilson, CB   +9 more
core  

The Cellular Response Capacity as Diagnostic Head Start in Neutrophil Endotoxemia Sensing

The FASEB Journal, Volume 40, Issue 10, 31 May 2026.
This study introduces the neutrophil cellular response capacity (CRC), a flow‐cytometry‐based approach for detecting prior endotoxin exposure across the inflammatory continuum in human whole blood. By comparing baseline and ex vivo restimulated neutrophil marker expression, the CRC identified low‐dose LPS exposure with greater analytical sensitivity ...
David Alexander Christian Messerer, Adam Omar Khalaf Mohamed, Lisa Wohlgemuth, Laura Vidoni, Christiane Leonie Knapp, Paul Müller, Bertram Dietrich Thomaß, Karl Föhr, Eberhard Barth, Manfred Weiss, Bettina Jungwirth, Kristina Nilsson Ekdahl, Bo Nilsson, Markus Huber‐Lang   +13 more
wiley   +1 more source

Algorithm-based effective recognition of acquired hemophilia A and other causes of isolated prolonged activated partial thromboplastin time within large blood sample series. [PDF]

Res Pract Thromb Haemost
Turincev P, Gomez F, Coutaz C, Quarroz S, Alberio L, Rufer N.   +5 more
europepmc   +1 more source

Dynamic changes of activated partial thromboplastin time and correlation with mortality in patients with severe fever with thrombocytopenia syndrome: A retrospective cohort study. [PDF]

PLoS Negl Trop Dis
Wang H, Fang S, Wang H, Zheng X.
europepmc   +1 more source

Utility of Activated Partial Thromboplastin Time Screening in Prospective Living Kidney Donors: A Single Center Cohort Study. [PDF]

Kidney Med
Wang LS, Ertmann E, Feldman E, Kossoff M, Lu B, Lin JC, Pishko A, Redfield R, Leonberg-Yoo A, Cuker A.   +9 more
europepmc   +1 more source

Activated Partial Thromboplastin Time [PDF]

, 2006
openaire   +2 more sources

A prolonged activated partial thromboplastin time indicates poor short-term prognosis in patients with hepatic encephalopathy: insights from the MIMIC database. [PDF]

Front Med (Lausanne)
Zhan L, Yang Y, Nie B, Kou Y, Du S, Tian Y, Huang Y, Ye R, Huang Z, Luo B, Ge L, Ye S.   +11 more
europepmc   +1 more source

Cytotoxicity after B.C.G. infection [PDF]

, 1974
B. Volkmann, Biozzi, Concord trial., Evans, Evans, Hibbs, Keller, Mathé, Mathé, Perlmann, U. Koszinowski   +10 more
core   +1 more source